AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
-3.99%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$76.7M
AUM Growth
+$76.7M
(-16%)
Cap. Flow
-$4.3M
Cap. Flow
% of AUM
-5.61%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
2
Closed
1
Top Buys
| 1 |
IOTS
Adesto Technologies Corporation Common Stock
IOTS
|
$17.4M |
Top Sells
| 1 |
Fate Therapeutics
FATE
|
$11.1M |
| 2 |
Kura Oncology
KURA
|
$6.88M |
| 3 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$3.74M |
Sector Composition
| 1 | Healthcare | 77.27% |
| 2 | Technology | 22.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
1
DELISTED
Rubius Therapeutics, Inc
RUBY
| $24.9M | 32.42% |
2,618,351
| – | – |
|
|
SYRS
2
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $22.9M | 29.84% |
3,313,817
-541,234
| -14% | -$3.74M |
|
|
IOTS
3
DELISTED
Adesto Technologies Corporation Common Stock
IOTS
| $17.4M | 22.73% |
+2,051,511
| New | +$17.4M |
|
|
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $5.94M | 7.74% |
1,196,776
| – | – |
|
|
5
Kura Oncology
KURA
$690M
| $5.59M | 7.28% |
406,307
-500,000
| -55% | -$6.88M |
|
|
6
Fate Therapeutics
FATE
$119M
| – | – |
-716,392
| Closed | -$11.1M |
|